English | Español
Patient Daily | Feb 4, 2026

Wageningen University receives ERC grant for targeted CRISPR-based cancer therapy
Patient Daily | Feb 4, 2026

Cardiology consults after non-cardiac surgery linked to fewer deaths and complications
Patient Daily | Feb 4, 2026

Palbociclib shows promise extending survival in HR+, HER2+ metastatic breast cancer
Patient Daily | Feb 4, 2026

Early tuberculosis treatment may improve survival rates among African HIV patients with sepsis
Patient Daily | Feb 3, 2026

FARE partners with Parche Oakland at Taste of the NFL for allergy-friendly dining
Patient Daily | Feb 3, 2026

How consumers can identify credible sources for evidence-based health decisions
Patient Daily | Feb 3, 2026

King's College London joins national effort to transform UK mental health research
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'

Trending
+ Regulatory
A. D. Alderman | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 16, 2026

PhRMA official: 'A program meant to help vulnerable patients shouldn't be treated like a business strategy'
+ Pharmaceuticals
Patient Daily | Jun 16, 2026

Intellia gene editing therapy shows strong results in hereditary angioedema study